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Tertiary lymphoid organs (TLOs) emerge during non-
resolving peripheral inflammation, but their impact
on disease progression remains unknown. We have
found in agedApoe/mice that artery TLOs (ATLOs)
controlled highly territorialized aorta T cell re-
sponses. ATLOs promoted T cell recruitment, primed
CD4+ T cells, generated CD4+, CD8+, T regulatory
(Treg) effector and central memory cells, converted
naive CD4+ T cells into induced Treg cells, and
presented antigen by an unusual set of dendritic cells
and B cells. Meanwhile, vascular smooth muscle
cell lymphotoxin b receptors (VSMC-LTbRs) pro-
tected against atherosclerosis by maintaining
structure, cellularity, and size of ATLOs though
VSMC-LTbRs did not affect secondary lymphoid
organs: Atherosclerosis was markedly exacerbated
in Apoe/Ltbr/ and to a similar extent in aged
Apoe/Ltbrfl/flTagln-cre mice. These data support
the conclusion that the immune system employs
ATLOs to organize aorta T cell homeostasis during
aging and that VSMC-LTbRs participate in athero-
sclerosis protection via ATLOs.1100 Immunity 42, 1100–1115, June 16, 2015 ª2015 Elsevier Inc.INTRODUCTION
A central tenet in immunology is that primary T cell responses are
initiated in secondary lymphoid organs (SLOs) (Mackay, 1999;
Mackay and von Andrian, 2001; Sallusto et al., 2004; Steinman,
2012; Woodland and Kohlmeier, 2009). In contrast, roles of ter-
tiary lymphoid organs (TLOs) have not yet been defined (Aloisi
and Pujol-Borrell, 2006; Drayton et al., 2006; Moyron-Quiroz
et al., 2004; Roozendaal andMebius, 2011). Although similarities
between SLOs and TLOs are apparent, major differences
deserve attention: SLOs form during ontogeny at predetermined
locations, trigger priming of naive T cells following interaction
with dendritic cells (DCs), and resume quiescence upon elimina-
tion of antigen (Miller et al., 2004). In contrast, TLOs emerge as
unencapsulated lymphoid aggregates in chronic inflammatory
diseases at undetermined locations in adult organisms (Gra¨bner
et al., 2009; Nathan and Ding, 2010; Weyand et al., 2001).
Though TLO neogenesis correlates with disease severity (Gal-
kina et al., 2006; Galkina and Ley, 2009; Gra¨bner et al., 2009;
Lopez-Diego and Weiner, 2008; Moyron-Quiroz et al., 2004),
their role has not been determined (Gra¨bner et al., 2009;
Mohanta et al., 2014).
We have observed that artery TLOs (ATLOs) emerge in
the aorta adventitia adjacent to atherosclerotic plaques in
Apoe/ mice during aging and that their size and structure
correlate with disease severity in a lymphotoxin b receptor
(legend on next page)
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(LTbR)-dependent way (Gra¨bner et al., 2009; Moos et al., 2005;
Zhao et al., 2004). We have also noticed that vascular smooth
muscle cells (VSMCs) of abdominal aorta segments that are
located between atherosclerotic plaques and ATLOs express
the lymphorganogenic cytokines, i.e., CCL21 and CXCL13
(Gra¨bner et al., 2009), that VSMCs express LTbRs in vivo, and
that LTbR signaling initiates transdifferentiation of VSMCs to a
lymphoid tissue organizer-like phenotype in vitro (Lo¨tzer et al.,
2010). These results are consistent with the view that media
VSMC-LTbRs transduce plaque-derived inflammatory cues to
the adventitia to promote ATLO neogenesis (Aloisi and Pujol-
Borrell, 2006; Drayton et al., 2006; Gebhardt et al., 2011; Geginat
et al., 2001; Glass and Witztum, 2001; Gra¨bner et al., 2009;
Groom and Luster, 2011; Hammerschmidt et al., 2008; Hansson
and Hermansson, 2011; Lichtman et al., 2013; Mohanta et al.,
2014; Moyron-Quiroz et al., 2004; Nathan and Ding, 2010; Roo-
zendaal and Mebius, 2011; Weber and Noels, 2011). In the pre-
sent study, we explored the impact of ATLOs on atherosclerosis
T cell responses and asked whether VSMC-LTbRs might partic-
ipate in disease progression. Our data reveal that the aging im-
mune system employs ATLOs to control atherosclerosis T cell
immunity and that VSMC-LTbRs maintain ATLO structure and
attenuate atherosclerosis.
RESULTS
Systemic T Cell Aging in Wild-Type and Apoe–/– Mice
T cell receptor-b+ (TCRb+) cells per renal lymph node (RLN),
spleen, and blood contracted by 50% during aging and the
magnitude of contraction was similar in Apoe/ and WT mice
(data not shown). Aging also altered the composition of T cell
subtypes: CD4+ T cell frequencies decreased by 20%–30%,
whereas CD4+Foxp3+ regulatory T (Treg) cells increased by
100% in SLOs and CD8+ T cells showed minor changes (Fig-
ures S1A and S2A). T cell activation and homing markers (Sher-
idan and Lefranc¸ois, 2011) were analyzed on T cell subtypes:
PD-1+ cells increased in all T cell subtypes, CD103+ cells
increased in CD4+ and Treg cells but decreased in CD8+ cells,
CD62L+ cells decreased in CD4+ and Treg cells, whereas they
remained unchanged in CD8+ T cells; however, CD69+ and
CXCR3+ cells increased in all T cell subtypes (Figures S1A and
S2A). Again, aging-associated changes remained identical in
Apoe/ versusWTmice. These data revealed large aging-asso-
ciated changes in T cell subtype composition and activation,
which was identical in Apoe/ and WT mice (see also Linton
and Dorshkind, 2004; Montecino-Rodriguez et al., 2013).
MIAME-compliant microarrays of Apoe/ and WT spleens
and blood (http://www.ncbi.nlm.nih.gov/geo/); deposited in the
NCBI Gene Expression Omnibus (GEO); accession number
GSE40156) revealed robust age-associated changes in total
gene-expression profiles and in gene ontology (GO) termsFigure 1. Transcript Atlases Reveal a High Degree of Territoriality of G
(A) Anatomy of WT and Apoe/ aortas and RLNs (left) and the numbers of differe
85-week-old mice. Student’s t test with Benjamini-Hochberg correction; n = 3 WT
ATLOs.
(B) Adventitia cluster show total differentially expressed genes (left) and mRNAs
(C) Plaque-ATLO cluster is shown in respective GO terms (right). Cluster analyse
intensities and statistics are reported in Table S1 (see also Figure S3).
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similar in Apoe/ versus WT mice (Figures S2D and S2E; Table
S1) (C.Y. and A.J.R.H., unpublished data). Transcript profiles of
WT aortas also showed age-associated changes (Figure S1B;
Table S1). However, unlike SLOs and blood, aged Apoe/
versusWT aortas indicated extensive changes in a large number
of overlapping and newly expressed transcripts (Figures S1B,
S2B, and S2C; Table S1).
mRNA Mapping of Tissue Microdomains Delineates the
Territoriality of Atherosclerosis Immune Responses in
the Aged Aorta
India ink in situ injections indicated that RLNs drain the abdom-
inal aorta (data not shown). A transcriptome atlas of abdominal
aortas and RLNs was constructed from aorta tissue microdo-
mains using laser capture microdissection (LCM)-derived micro-
arrays (Figure 1A) (C.Y. and A.J.R.H., unpublished data). Lesion
development in Apoe/ mice is primarily a function of lipid
accumulation, and inflammation is secondary. To assess the
territoriality of inflammation and of immune responses in arterial
wall laminae and their corresponding aorta-draining RLNs, we
analyzed transcript atlases in detail. Apoe/ and WT RLN
maps were virtually identical (Figure 1A, S3B, S3G, and S3H;
Table S1) sharply contrasting with large numbers of differentially
expressed transcripts in ATLOs versus WT adventitia, ATLOs
versus Apoe/ adventitia without plaque, and ATLOs versus
plaques (Figures 1A, S3A, S3C, and S3D; Table S1). More
comprehensive information was obtained using three-tissue
comparisons. The adventitia cluster showed large overlaps be-
tweenWT adventitia andApoe/ adventitia without plaque con-
trasting with transcripts expressed by adjacent ATLOs (Figures
1A, 1B, S3C, and S3D). The plaque-ATLO cluster indicated pre-
dominant expression of T cell-regulating genes in ATLOs versus
inflammation-regulating genes in plaques (Figures 1C, S3E, and
S3F) and the LN cluster revealed that ATLOs predominantly ex-
pressed inflammatory response-related genes when compared
to RLNs (Figures S3B, S3G, and S3H).
ATLOs Are T Memory Cell Homing Sites
The majority of aorta T cells in aged Apoe/mice are present in
the adventitia (Gra¨bner et al., 2009; Moos et al., 2005). ATLO
T cells corresponded to CD4+, CD8+, CD4+ Treg cells, and few
CD8+ Treg cells (Figures 2A and 2B). During primary immune re-
sponses in SLOs CD62LCD44+ T effector memory (TEM) and
CD62L+CD44+ T central memory (TCM) cells are generated
from naive CD4+ T cells (Mackay, 1999; Mackay and von
Andrian, 2001; Sallusto et al., 2004; Steinman, 2012; Woodland
and Kohlmeier, 2009). Naive CD4+ T cells were rare in ATLOs
(Figure 2C). Indeed, the large majority of ATLO CD4+ T cells
were TEM cells yielding a 27-fold ratio of TEM versus naive cells
(Figure 2C). Treg cells also had a TEM phenotype yielding anene Expression in the Arterial Wall
ntially expressed mRNAs in two-tissue comparisons (right) are shown of 78- to
and Apoe/mice except n = 4 for Apoe/ adventitia no plaque and n = 4 for
in respective GO terms (right).
s were performed using ANOVA with Benjamini-Hochberg correction. Signal
Figure 2. ATLOs Harbor Distinct Sets of TCRb+ T Cell Subtypes
(A) T cell abundance in ATLOs versus plaques. Immunofluorescence detection of 78- to 85-week-old Apoe/CD4+ Treg cells, and CD8+ T cells in ATLOs versus
plaques (P) (two left panels); CD4+ Treg cells (middle; open arrows); CD4 Treg cells (middle; closed arrow); CD8+ Treg cells (second right; closed arrow); and
CD103+ Treg cells (right; closed arrows) in T cell areas (n = 3 mice). Dotted lines indicate media. DAPI stains nuclei. Scale bars represent 50 mm for two left panels
and 100 mm for three right panels.
(B) Lymphocyte subsets in ATLOs. Flow cytometry plots show ATLO CD4+Foxp3 T cells, CD4+Foxp3+ Treg cells (left), and CD8+ T cells (right) from the TCRb+
cell gate of 78- to 85-week-old Apoe/ mice.
(legend continued on next page)
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effector memory Treg versus naive Treg cell ratio of 86 fold.
Similar results were obtained for CD8+ T cells (Figure 2C). The
composition of ATLO memory cells contrasted to that in
SLOs and blood, which contained fewer TEM cells (Figure 2C).
There was no systemic alteration in any memory T cell subtype
in liver, lung, and other peripheral tissues between the mouse
genotypes (data not shown). These data showed that TEM and
TCM T cells dominate in ATLOs when compared to their SLO
counterparts.
ATLOs Educate Aorta T Cells
Tissue-specific homing and education of TEM and TCM cells is
essential for long-term immunosurveillance in peripheral tissues.
To achieve effective immunosurveillance, the immune system
educates memory cells to express functionally relevant tissue
homing molecules (Lathrop et al., 2011; Lathrop et al., 2008;
Mackay, 1999; Mackay and von Andrian, 2001; Mikhak et al.,
2013; Sallusto et al., 2004). T cell tissue tropism has been studied
in skin and intestine (Sheridan and Lefranc¸ois, 2011), but little is
known about atherosclerosis. We determined expression of pro-
totypic homing and function-associated markers (Sheridan and
Lefranc¸ois, 2011). Sizable populations of ATLO CD4+ and
CD8+ T cells were CD103+ and PD-1+ (Figures S4A and S4C).
70% of Treg cells expressed CD103 and 79% expressed PD-1
contrasting with ATLO CD8+ T cells (Figures S4B and S4C).
While CD69 was expressed in 44% of ATLO CD4+ and CD8+
T cells, >80% of Treg cells expressed CD69 (data not shown).
In contrast, CD103, CD69, and PD-1 were low on T cells in
SLOs and blood and expression was identical or changes were
small in Apoe/ versus WT mice (Figure S4; data not shown).
When compared to SLOs, all ATLO T cell subtypes showed
low expression of the chemokine receptors CXCR3, CCR4,
and CCR7, as well as CD122, though comparably higher
Tnfrsf18 (tumor necrosis factor receptor superfamily member
18; also referred to as glucocorticoid-induced tumor necrosis
factor receptor-related gene, i.e., GITR; data not shown). Thus,
all T cell subtypes and in particular ATLO Treg cells showed
strong atherosclerosis education signatures. The magnitude of
T cell education in atherosclerosis is further illustrated by
comparing ATLO Treg cell phenotypes with those in a mouse
model of systemic multiorgan inflammation, i.e., Relb/ mice
(Weih et al., 1995). Although Relb/ spleen, lung, liver, and
blood showed increased numbers of CD103+PD1+CD62L
CD25+ Treg cells, they fell short of those in ATLOs by a large
margin (Figure 2D). Moreover, non-obese diabetic (NOD) mouse
SLOs and pancreases (i.e., a model of autoimmune diabetes) did
not reveal educated T cells (data not shown).
ATLOs Direct Naive CD4+ and Naive CD8+ T Cell Homing
by Enhanced Recruitment and Decreased Egress
Recruitment of naive T cells in SLO-sufficient mice has not
been studied in any TLO (Woodland and Kohlmeier, 2009). To(C) Naive and TEM cells in ATLO T cell subsets. Abundance of TEM cells (CD62L
C
Treg cells, and CD8+ T cells in ATLOs versus RLNs, spleen, and blood of 78- to
(D) ATLO Treg cell phenotype. 40% of ATLO Treg cells are CD103+PD1+CD62LC
LN, and in 9- to 12-week-young WT and Relb/ spleen, lung, liver, and blood. F
pooled one to two mice per genotype per experiment with two technical replicate
corrected for multiple testing (Bonferroni) were estimated using the GEE model.
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consider two issues: naive T cells egress SLOs via efferent
lymph vessel sphingosine 1-phosphate receptor type 1
(S1PR1), and the recirculation rate of naive T cells in SLOs is
constitutively high. Consequently, the presence of TEM or TCM
cells in SLOs or ATLOs cannot be taken as evidence for
their local generation (Schwab and Cyster, 2007). Hence,
demonstration of participation of ATLOs in naive T cell
recruitment in atherosclerosis requires that T cell recirculation
had to be prevented. Application of the S1PR1 antagonist
FTY720 in spleen-sufficient mice led to a reduction of blood
T cells by >95% and increased numbers in SLOs, indicating
that T cell recirculation was largely but not entirely prevented.
As FTY720 is less effective in preventing spleen T cell
egress, splenectomy was required in addition to FTY720 treat-
ment. Thus, a combined splenectomy and FTY720-treatment
approach was adopted (Matloubian et al., 2004). In splenec-
tomized and FTY720-treated mice, the total number of re-
cruited naive CD4+ T cells was higher in Apoe/ adventitiae,
ATLOs, and in Apoe/ and WT RLNs when compared to their
untreated counterparts (Figure 3A). Furthermore, Apoe/
aortas recruited >3 times more cells when compared to WT
aortas and Apoe/ abdominal aorta recruited markedly more
naive CD4+ T cells when compared to the thoracic aorta (Fig-
ure 3A). These data indicated that naive CD4+ T cell recircula-
tion in both Apoe/ and WT adventitiae is at least in part
regulated by egress via S1PR1. However, Apoe/ and WT
RLNs recruited similar numbers of naive CD4+ cells within
24 hr (Figure 3A). We observed that S1pr1 mRNA expression
was >40% lower in ATLOs when compared to ATLO-free
abdominal aorta adventitia in the transcriptome atlas (data
not shown). For naive CD8+ T cells, similar data were obtained
(data not shown). When leukocyte recruitment was determined
using multiphoton laser-scanning microscopy (MPLSM), ATLOs
showed 10-fold homing rates when compared to WT aortas at
24 hr (Figure 3A). The first stages of naive T cell priming in
SLOs, i.e., immigration and activation (see below), occur within
24 hr (Mempel et al., 2004; Miller et al., 2004). To examine the
long-term fate of naive CD4+ T cells, we transferred flow
cytometry-purified Ly5.1 T cells into aged Ly5.2 Apoe/ or
WT mice and aortas and SLOs were analyzed after 3 weeks.
Apoe/ aortas retained >10-fold more T cells versus WT
aortas (Figure 3A, lower right panels). These data indicated
that ATLOs have a large capacity to recruit naive T cells into
the arterial wall and generate TEM cells (Figure 3A). In support
of clonal expansion of ATLO T cells, we noticed large numbers
of CD3+Ki67+ T cells (data not shown). Apoe/ RLNs and
spleen also showed higher numbers of transferred naive
CD4+ T cells after 3 weeks when compared to those in WT
mice consistent with the possibility that ATLOs mediate priming
and generation of TEM cells followed by their subsequent migra-
tion into SLOs (data not shown).D44+), TCM cells (CD62L
+CD44+), naive cells (CD62L+CD44) in CD4+ T cells,
85-week-old Apoe/ mice.
D25+ contrasting to those in 78- to 85-week-old WT and Apoe/ spleen and
low cytometry data are representative of three independent experiments with
s (B and C), or with one mouse per genotype (D). Means ± SEM, and p values
*p% 0.05; **p% 0.01; ***p% 0.001 (see also Figure S4).
Figure 3. ATLOs Recruit Naive CD4+ T Cells into the Diseased Arterial Wall and Alter Lymphocyte Motility
(A) Recruitment of naive CD4+ T cells. Experimental approach with 78- to 85-week-old recipient and 9- to 12-week-old donor mice. Ly5.1 naive CD4+ (CD4+
CD62L+CD69CD25CD44) T cells were analyzed at 24 hr (upper three right panels) or after 3 weeks (lower two right panels) in total aortas (upper left, red
columns), aorta segments (upper middle, red columns), and/or RLNs (upper right, red columns). Control mice were not splenectomized or FTY720-treated (WT
open columns; Apoe/ mice black columns). Means ± SEM of upper three and lower two right panels (n = 3 experiments with one mouse per genotype per
experiment) were determined by two-sided Student’s t test. *p% 0.05, **p% 0.01, ***p% 0.001. Leukocyte density in Apoe/ (n = 8 mice) or WT (n = 11 mice)
abdominal adventitiae was determined by MPLSM 24 hr after i.v. injection of CMTPX-labeled leukocytes (lower left panel). A two-tailed Wilcoxon-Mann-Whitney
test was applied on mouse means.
(B) Leukocyte movement. 3D plots of leukocyte movement in ATLOs orWT adventitiae were generated fromMPLSM by placing the starting point of each track at
the origin of the axes (Movies S1 and S2). Scale bars represent 80 mm; Scale red axis represents 10 mm.
(C) Leukocytemotility. Parameters: length, track velocity, and displacement were determined byMPLSM in 78- to 85-week-oldApoe/ (n = 8mice) orWT (n = 11
mice) abdominal aorta adventitiae or in Apoe/ (n = 9 mice) or WT (n = 9 mice) popliteal LNs (pLNs) as described in the Experimental Procedures. Two-tailed
Wilcoxon-Mann-Whitney test corrected for multiple testing (Bonferroni) was performed on mouse means. *p% 0.05, **p% 0.01, ***p% 0.001.
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ATLO T Cells Acquire Movement Parameters
Resembling Those in LNs
Naive T cell priming in SLOs (Miller et al., 2004; Schneider et al.,
2006) requires specificmigration characteristics in T cell areas to
allow extended T cell-DC interactions. We used MPLSM (Maffia
et al., 2007) to compare T cell movement in ATLOs with those in
the WT adventitia and LNs (Miller et al., 2004). Adoptively trans-
ferred CMTPX-labeled leukocytes were examined at 24 hr.
Numerous cells were visible in ATLOs though few cells were
detectable in WT adventitia (Figure 3B). Cell movement was
greatly enhanced in ATLOs (Figure 3B), whereas cells in WT
aortas were nearly motionless with cell movement confined to
a radius of 10 mm (Figures 3B and 3C; Movie S1). In contrast,
cells moved rapidly in ATLOs and cells that migrated >100 mm
were observed in each of 8 Apoe/mice (Figure 3B right panel;
Figure 3C left panel; Movie S2). In addition to increased track
velocity (3.7-fold increase, p < 0.001; Figure 3C middle panel),
cells in ATLOs showed increased displacement (2.6-fold, p <
0.05; Figure 3C right panel) typical for the behavior of naive
T cells in LNs (Zinselmeyer et al., 2005). We directly compared
movement in Apoe/ versus WT peripheral LNs that do not
drain the atherosclerotic aorta, i.e., popliteal LNs (pLNs). How-
ever,movement parameters inApoe/ andWTpLNswere iden-
tical (Figure 3C, right panel).
ATLOs Activate and Convert Naive CD4+ T Cells into
Induced Treg Cells
To compare activation of naive T cells in Apoe/ andWT aortas
and SLOs, we examined naive CD4+ T cells for CD62L and CD69
expression at 24 hr in splenectomized and FTY720-treated aged
mice (Figure 3A, left panel). WT aortas induced CD69 and down-
regulated CD62L in 10% and 17% of TCRb+ Ly5.1 naive
CD4+ T cells, respectively, whereas ATLOs induced CD69 and
downregulated CD62L in 47% and57% of Ly5.1 naive
CD4+ T cells, respectively (Figure 4A). No differential naive
CD4+ T cell activation by Apoe/ versus WT RLNs was
observed (Figure 4A). Likewise, naive CD8+ T cells were selec-
tively recruited, activated, and educated by ATLOs in Apoe/
mice but not byWT aortas, orWT andApoe/RLNs (Figure S5).
We examined whether Treg cells were similarly activated by
ATLOs using GFP-Treg cells purified from spleens and LNs of
transgenic Foxp3-DTR-GFP mice (Kim et al., 2007). However,
we failed to observe a similar activation by ATLOs: Foxp3+-
GFP cells remained CD103loPD-1loCD25+CD62L+ even 3 weeks
after transfer contrasting to their endogenous Treg cell counter-
parts (Figure 2D; data not shown). These data suggested that the
majority of aorta-educated endogenous ATLO Treg cells (Fig-
ure 2D) might result from clonal selection whose steady-stateFigure 4. ATLOs Prime Naive CD4+ T Cells and Convert Some of Them
(A) Activation of naive CD4+ T cells in situ. 78- to 85-week-old Apoe/ or WT mi
cells were analyzed by flow cytometry at 24 hr in total aortas or RLNs for CD62L an
among recruited cells (lower panel) (see also Figures S5).
(B) nTregs and iTregs in ATLOs. CD4+Foxp3+ Treg cells in ATLOs were analyzed
(C) Frequencies of iTreg cells in total CD4+Foxp3+ Treg cells.
(D) Conversion of naive CD4+ cells into iTregs. Experimental approach to determi
cells (left), and flow cytometry shows the converted Foxp3+ iTreg cells from the
(E) Quantification of converted iTreg cells frommigrated naive CD4+ T cells 3 wee
experiments with one mouse per genotype per experiment. Two-tailed Student
multiple testing (Bonferroni) for (C). *p% 0.05, **p% 0.01, ***p% 0.001.homeostasis from adoptively transferred cells might not be
achievable within 3 weeks. We next reasoned that ATLOs might
participate in peripheral conversion of naive CD4+ T cells into
inducedHelios iTreg cells known to restrict the effector function
of TEM cells with high efficiency (Bilate and Lafaille, 2012). We
first analyzed endogenous ATLO Treg cells for Helios expres-
sion. 18% of all ATLO Treg cells were Foxp3+Helios iTreg
cells (Figures 4B and 4C). To examine peripheral conversion of
naive CD4+ T cells into iTreg cells, we transferred Ly5.1 naive
CD4+ T cells into recipient mice and analyzed their correspond-
ing aortas and SLOs after 24 hr or 3 weeks. No iTreg cell gener-
ation could be observed within 24 hr. However, after 3 weeks,
Apoe/ aortas had converted 30% whereas WT aortas had
converted only5%of themigrated naive CD4+ T cells into iTreg
cells (Figures 4D and 4E). WT RLNs and spleens showed low
naive CD4+ T cell conversion into iTreg cells (Figure 4E). The ab-
solute number of iTreg cells was 38-fold higher in Apoe/when
compared to WT aortas (Figure 4E).
ATLOs Show an Aberrant Composition of Antigen-
Presenting Cells
Intima DCs expand during atherogenesis in young cholesterol-fed
Ldlr/ mice (Choi et al., 2011; Weber et al., 2011). We had
observed earlier that ATLOs (Gra¨bner et al., 2009; Moos et al.,
2005; Zhao et al., 2004) contain cDCs, macrophages, and
B cells. Here, we characterized the lineages and functional activ-
ities of the major ATLO APCs. Staining of ATLOs for PDCA1 and
Siglec-H showed that PDCA1+ was widely expressed, whereas
Siglec-H was expressed only on few cells, i.e., plasmacytoid
DCs (pDCs) (Figures 5A and 5B). To avoid contamination of
ATLO DCs by previously described intima DCs (Choi et al., 2011),
we removedatherosclerotic plaques before aorta cell suspensions
were prepared. PDCA1+Siglec-H+ pDCsweremajor histocompat-
ibility complexmolecule class II low (MHC-IIlo) (Figure 5B, P2), and
1%–2% CD45+ cells were CD11cloSiglec-H+ pDCs. 80% of
the CD11chiMHC-II+ APCs were CD11b+DC-SIGN+ mDCs
(myeloid DCs), 15% CD11b+DC-SIGN cDCs (conventional
DCs), and5%CD11bDC-SIGN lyDCs (lymphoid DCs), while
the MHC-II+CD11clo/ APCs harbored 80% CD19+CD11b B
cells, and 10% CD19CD11b+ macrophages (Figure 5C).
ATLO APCs Present Exogenous Antigen In Vivo
Two models of in vivo antigen presentation were established. At
24 hr after transfer of transgenic OT-II CD4+ T cells followed by
OVA or PBS intravenous (i.v.) administration, ATLOs of aged
Apoe/CD11c-YFP mice were examined (Figure 5D). ATLOs
in Apoe/CD11c-YFP mice showed long-lasting clustering of
OT-II CD4+ T cells with YFP+ DCs confirming and extendinginto iTreg Cells
ce were splenectomized and FTY720-treated as described in Figure 3A. Ly5.1
d CD69 expression (upper panel), and their absolute numbers and frequencies
for Helios expression.
ne naive CD4+ (CD4+CD62L+CD69CD25CD44) T cell conversion into iTreg
transfer cell gate after 3 weeks.
ks after transfer. Data are representative of three (A, D, and E), or four (B and C)
’s t test for (A) and (E); two-tailed Wilcoxon-Mann-Whitney test corrected for
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Figure 5. ATLOs Present Antigen by an Unusual Set of APCs
(A) PDCA1+ and Siglec-H+ cells in ATLOs. Immunofluorescence staining show preferential location of Siglec-H+ pDCs in CD3+ T cell area (T) of ATLO and at higher
magnification of boxed area (first two panels), the staining of PDCA1+ cells in ATLO T cell area and 3D-reconstructed colocalization of PDCA1 with Collagen IV in
HEV endothelial cells (second two panels), and 3D-reconstructed co-staining of Siglec-H with Collagen IV in ATLO blood vessels (BV) and CD11c (third two
panels; n = 3 mice).
(B) pDCs are MHC-IIlo. Flow cytometry analyses show co-staining of PDCA1 and Siglec-H on ATLO CD45+ cells (left) and MHC-II expression on
PDCA1loSiglec-H cells (P1) and PDCA1hiSiglec-H+ cells (P2)(right).
(C) Gating strategy for APCs. Flow cytometry plots show the gating strategy for APC subtypes in pre-gated CD45+ cells from plaque-removed abdominal
aorta.
(D) OT-II T cells-ATLO cDC interactions. 3D image of ATLO OT-II T cell-DC interactions in situ (n = 8 mice). Grid Unit = 42.6 mm. Projection: Lumen toward
adventitia. T cells are red, DCs are green (see also Movies S3 and S4).
(E) Approach for Ea or PBS injection.
(legend continued on next page)
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previous observations obtained by others in in vitro added T cells
(Koltsova et al., 2012) (Figure 5D; Movies S3 and S4). To deter-
mine which APC type(s) present antigen in ATLOs, we em-
ployed the Ea/Y-Ae system (Itano et al., 2003) using the model
antigen Ea-GFP together with the Y-Ae monoclonal antibody
recognizing the Ea peptide in the context of MHC-II (I-Ab).
Aged Apoe/mice received either Ea-GFP or PBS i.v., and pre-
sentation of antigen was assessed by flow cytometry (Figures
5E–5G) (Macritchie et al., 2012). All Y-Ae+ cells in the abdominal
aorta were MHC-IIhi (data not shown). Prototypic DC subtype
markers showed that 55% of MHC-IIhiY-Ae+ APCs were
CD11c+CD11b+DC-SIGN+ mDCs, 24% were CD11c-/lo
CD11bCD19+ B cells, 12% CD11c+CD11b+DC-SIGN cDCs,
4% CD11c/loCD11b+CD19 macrophages, and 2%
CD11c+CD11bDC-SIGN lyDCs (Figure 5H). To study the
origin of ATLO mDCs, we transferred flow cytometry-purified
Ly5.1 bone marrow monocytes (CD115+CD11cloCD11b+F4/80+
Ly6C+Ly6GloPDCA1) to aged Apoe/ mice. Donor bone
marrow monocytes in spleen and RLNs of Apoe/ recipients
were CD11cPDCA1, whereas they were CD11c+PDCA1+
CD11b+F4/80+ in ATLOs after 1 week (data not shown). These
data indicated that bone marrow monocytes migrate into ATLOs
and locally differentiate into mDCs (Cheong et al., 2010).
PDCA1+Siglec-H+ pDCs represented a minor fraction in ATLOs
though none of them were Y-Ae+ consistent with low expression
of MHC-II (Figure 5B). In summary, these results suggest that
mDCs followed by B cells, macrophages, cDCs, and lyDCs are
the major ATLO APCs.
The Immune System of VSMC-Ltbr–/– Mice Is
Indistinguishable from that of WT Mice
The role of TLOs in unresolvable inflammatory diseases remains
unknown. Experimental approaches to unambiguously address
this issue have not emerged (Aloisi and Pujol-Borrell, 2006;
Mohanta et al., 2014; Pitzalis et al., 2014; Weyand et al., 2001).
To make attempts to overcome this major obstacle, we took
advantage of previous observations in aged Apoe/ mice:
The lymphorganogenic chemokines, i.e., CXCL13 and CCL21,
are selectively expressed in VSMCs that are sandwiched be-
tween atherosclerotic plaques and ATLOs of aged Apoe/
mice; agonistic LTbR antibodies trigger CXCL13 expression in
WT VSMCs, but not in Ltbr/ VSMCs, in vitro(Lo¨tzer et al.,
2010); and antagonistic LTbR antibodies disrupt ATLO structure
and attenuate aorta Cxcl13 mRNA in vivo(Gra¨bner et al., 2009).
These data raised the important possibility that VSMC-LTbRs
might participate in ATLO neogenesis as lymphoid tissue orga-
nizer cells. Furthermore, we speculated that if ATLOs were to
be impacted by VSMC-LTbRs, then they might also affect
atherosclerosis. Following these lines of thought, we reasoned
that selective blockade of the putative LTbR signaling pathway
in VSMCs should interfere with ATLO neogenesis without
affecting the immune system systemically. To evaluate this hy-
pothesis, we generated Apoe/Ltbrfl/flTagln-cre mice to delete(F) Y-Ae+ cells in ATLOs. Flow cytometry plots indicate Y-Ae+ cells among CD45+
(G) Y-Ae+ APC subtypes. Histograms show comparisons of Y-Ae expression in
injected mice.
(H) Composition of ATLO APCs. Pie chart depicts the composition of Ea-present
12 weeks old). Flow cytometry data are representative of four experiments withthe LTbR selectively in VSMCs (Boucher et al., 2003; Lepore
et al., 2005) (Figure 6A). Because controls for hyperlipidemic
mice that lack LTbRs systemically and show multiple defects
of their immune system (Fu¨tterer et al., 1998; Stopfer et al.,
2004), we also generated Apoe/Ltbr/ mice (Figure 6A).
BothApoe/Ltbrfl/flTagln-cre andApoe/Ltbr/mice showed
concentrations of plasma lipids that were identical to those of
their Apoe/ counterparts (Figure S6A). We next studied the
immune systems of WT, Apoe/, their control brethren, i.e.,
Ltbr/ and Apoe/Ltbr/ mice, and Ltbrfl/flTagln-cre and
Apoe/Ltbrfl/flTagln-cremice. Young and aged Apoe/Ltbr/
or Ltbr
/
mice lacked LNs and Peyer’s patches (Figure 6B, data
not shown). We observed disruption of spleen structure,
including a lack of germinal center (GC) B and marginal zone
(MZ) B cells (Figure 6C), of spleen follicular dendritic cells
(FDCs) (Figure 6D), of spleen marginal metallophilic macro-
phages (Figure S6B), and blood vessels of spleen white pulp
(Figure S6B) though numbers of LN fibroblastic reticular cells
(FRCs) (Figure 6E) and the composition of T cell subsets in
spleen were comparable to those of WT mice (Figure 6F).
However, compared to aged WT mice, Ltbr/ mice showed
increased ratios of TEM/naive splenic and blood T cell subsets
(Figures 6G and S6C), higher numbers of splenic CD103+CD4+
T cells (Figure 6H), lower numbers of splenic CD8+CD103+
T cells (Figure S6D), higher numbers of CD4+CD103+ T cells in
blood, and lower numbers of CD103+ Treg cells in blood (Fig-
ure S6D), lower or equal numbers of CD4+PD-1+, PD-1+Treg
T cell subsets, and increased numbers of splenic and blood
CD8+PD-1+ T cells (Figures S6E and S6F), slightly lower numbers
of DCs (not significant due to high variability) and higher numbers
of splenic macrophages (Figure S6G), and leukocyte infiltrates
in nonlymphoid tissues (Figure 6I). In contrast, young and aged
Apoe/Ltbrfl/flTagln-cre or Ltbrfl/flTagln-cre mice did not show
comparable changes of these abnormalities (Figures 6 and S6).
These data provide evidence that Apoe/Ltbrfl/flTagln-cre
mice do not show major systemic alterations of their immune
system.
VSMC-LTbRs Maintain ATLO Structure and Protect
against Atherosclerosis
Both 32- to 35-week-old and 78- to 85-week-old Apoe/
Ltbr/ mice revealed markedly accelerated atherosclerosis as
evidenced by increased en face lipid staining and intima media
ratios (Figures 7A and 7B). However, 32- to 35-week-old
Apoe/Ltbrfl/flTagln-cre mice did not show augmented athero-
sclerosis (Figure 7A), indicating that the VSMC-LTbR does not
affect the early stages of the disease. However, both aged
Apoe/Ltbr/ and aged Apoe/Ltbrfl/flTagln-cre mice
showed aberrant ATLO structures as revealed by the reduced
size of ATLOs, loose T and B cell infiltrates, loss of separate T
and B cell areas, and a complete absence or amarkedly reduced
number of high endothelial venules (HEVs) in ATLOs, respec-
tively (Figures 7B–7D). However, aged Apoe/Ltbrfl/flTagln-crecells from plaque-removed ATLO-bearing abdominal aorta segments as in C.
mDCs, B cells, cDCs, macrophages, lyDCs and pDCs from PBS- or Ea-GFP-
ing APCs in ATLOs (recipient mice 78- to 85 weeks old, donor OT-II mice 9- to
one mouse per genotype per experiment (B, C, and E–H).
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mice revealed robust acceleration of atherosclerosis whose
magnitude was indistinguishable from that of age-matched
Apoe/Ltbr/ mice (Figure 7A) and this acceleration was
greater in the abdominal aorta when compared to other
parts of the arterial tree (Figure 7B). These data indicate that
VSMC-LTbRs maintain ATLO structure and cellularity and pro-
tect against atherosclerosis in a site-specific and age-depen-
dent way.
DISCUSSION
This study has identified ATLOs as the principal lymphoid tissue
that controls atherosclerosis T cell responses during aging and
suggests that VSMC-LTbRs protect against atherosclerosis by
maintaining ATLO structure and cellularity.
ATLO activities are selective and robust involving major steps
of an antigen-specific primary T cell response: Recruitment of
naive T cells, modulation of T cell motility toward characteristics
of those in SLOs, activation of naive CD4+ and naive CD8+
T cells, antigen presentation, generation of CD4+, CD8+, and
Treg memory cells, education of TEM and TCM cells, and conver-
sion of naive CD4+ T cells into iTreg cells. Thus, the immune
response in atherosclerosis is carried out in the adventitia during
aging though it is assumed to be organized in plaques and/or in
SLOs in young mice. Together with the systemic age-associated
changes of all T cell compartments, these data suggest the para-
digm that the senescent immune system is capable of selectively
employing a TLO to organize unresolvable disease-specific im-
mune responses.
A fundamental unanswered question in the immunology of un-
resolving inflammation relates to the impacts of TLOs in any dis-
ease setting. Although there is correlative evidence that TLOs
can afford disease protection in certain acute pathogen-trig-
gered diseases and cancers (Aloisi and Pujol-Borrell, 2006;
Drayton et al., 2006; Mohanta et al., 2014; Moyron-Quiroz
et al., 2004; Pitzalis et al., 2014; Roozendaal and Mebius,
2011), circumstantial evidence including clinical association
studies has led investigators to assume that TLOs enforce rather
than attenuate chronic inflammation and—in particular—autoim-Figure 6. The Immune System of VSMC-LTbR Deficient Mice
(A) Ltbr deletion in VSMCs. Validation of genomic Ltbr deletion in freshly isolated a
of floxed Ltbr sequences in cultured aortic VSMCs compared to aortic endothelial
control.
(B) SLO neogenesis. Inguinal LNs (ILNs) were visualized by India ink injection into f
not shown) show similar results. SLOs in WT, Ltbr/, and Ltbrfl/fl Tagln-cre mice
(C) GC and MZ B cells in spleen. PNA+ GC B cells and IgD+ follicular MZ B cel
cytometry show GC (middle panel) and MZ B cells (lower panel) in B220+ B cells
(D) FDCs in spleen. Representative lower magnification montages of CD35+ FD
genotype).
(E) FRCs in LNs. Flow cytometry of Gp38+CD31 FRCs of CD45Ter119 cells i
(F) T cell subsets in spleen. Flow cytometry of CD4+Foxp3 T cells, CD4+Foxp3+ T
mice.
(G) TEM and naive T cells in spleen. Flow cytometry of CD62L
+CD44 naive, CD62
old mice; TEM per naive T cell ratios of CD4
+ T cells (upper panel) or CD4+ Treg c
(H) CD103+ cells in spleen. Flow cytometry plots showCD103+ cells fromCD4+ (up
show the percentage comparison of CD103+ cells among CD4+ T or Treg cells a
(I) Perivascular infiltrates in peripheral tissues. Hematoxylin and eosin (H/E) stainin
mice per genotype. Br, bronchiole. Scale bar represents 50 mm (C and I); 500 mm (D
to twomice per genotype per experiment (C and E–H). Data represent means ± SE
(Bonferroni) using the GEE model as described in the Experimental Procedures.mune diseases (Aloisi and Pujol-Borrell, 2006; Pitzalis et al.,
2014; Weyand et al., 2001). Direct evidence for this proposition,
however, would require blockade of TLO function without
affecting the immune system systemically. This has not been a
viable option in the past because molecules that specifically
regulate TLO neogenesis in adult organisms as opposed to those
that regulate SLO formation during ontogeny have not been
identified (Drayton et al., 2006; Fu¨tterer et al., 1998; Roozendaal
and Mebius, 2011). Yet, data reported here show that the struc-
ture and cellularity of a TLO can be altered without affecting
SLOs. This was possible by targeting the LTbR of VSMCs using
the late differentiation marker of these cells, i.e., SM22a/Trans-
gelin (Boucher et al., 2003). Together with the evidence that
Apoe/Ltbrfl/flTagln-cre or Ltbrfl/flTagln-cre mice lacked
changes of SLO structure and cellularity when compared to
SLOs of Apoe/Ltbr/ or Ltbr/ mice but developed major
alterations of ATLOs indicate that TLOs in other peripheral in-
flammatory and autoimmune diseases could also be targeted.
Distinct immune cells (i.e., the lymphoid tissue inducer cells),
are known to interact with LTbRs on stromal mesenchymal cells,
i.e., the stromal organizer cells that give rise to fibroblastic retic-
ular cells (FRCs) in adult SLOs, to form SLOs during ontogeny
(Roozendaal and Mebius, 2011). The observation that Apoe/
Ltbrfl/flTagln-cre mice showed disruption of ATLO structure and
size supports the view that VSMCs can adopt lymphoid tissue
organizer-like characteristics in advanced atherosclerosis.
Regarding the possible protection from atherosclerosis by
ATLOs in aged mice, several aspects of our data merit attention:
ATLOs generate both pro-inflammatory TEM and TCM cells and
anti-inflammatory nTreg and iTreg cells (Ait-Oufella et al.,
2006). However, immunosuppressive leukocytes appear to
restrict their effector counterparts under the pathogen-free con-
ditions used in this study. Possibly, the highly activated ATLO
nTreg and iTreg cells shift the balance between pro-atherogenic
and anti-atherogenic T cell subtypes toward inhibition of immune
responses by restricting activation in and the release of TEM and
TCM cells from ATLOs. It will be a challenge for future studies to
identify the specific roles of ATLO iTreg cells on atherosclerosis.
Moreover, B cell subsets in ATLOs remain to be characterizedortic VSMCs by PCR (left) and of LtbrmRNA (middle); qRT-PCR show reduction
cells (ECs) (n = 3 experiments) of Ltbrfl/flTagln-cremice (right); NTC, no template
ootpads of 8- to 10-week-oldmice (n = 8) (left panels, arrow); all other LNs (data
(n = 8) (right); RLN, renal LN; PP, Peyer’s patches; Abs, absent.
ls in spleen (upper panel) (n = 8–12 sections in 5–7 mice per genotype). Flow
from 78- to 80-week-old mice.
Cs and quantification of FDCs in spleen (n = 8–12 sections in 5–7 mice per
n LNs of 78- to 90-week-old mice (left panel).
reg cells, and CD8+ T cells of TCRb+ cells of 78- to 90-week-old Ltbrfl/flTagln-cre
LCD44+ TEM, and CD62L
+CD44+ TCM cells of CD4
+ T cells of 78- to 90-week-
ells (lower panel).
per panel) or Treg (lower panel) cell gate of 78- to 90-week-oldmice; bar graphs
t right.
g show leukocyte infiltrates around blood vessels (BVs) in lungs and liver. n = 3
). Flow cytometry data are representative of three experiments with pooled one
M; p values were determined by unpaired Student’s t test or by multiple testing
*p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant (see also Figure S6).
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Figure 7. VSMC-LTbRs Protect against Atherosclerosis
(A and B) Atherosclerotic plaque and ATLO sizes. Sudan-IV-stained aortas of young (32–35 weeks; n = 3) and aged (78- to 85 weeks old; n = 4–6) mice (A, upper
panel), andOil red O/hematoxylin stained innominate arteries (n = 3–8) and abdominal aortas (n = 4–8) (B, upper panel). Atherosclerotic lesions in different parts of
the aorta were quantified as percentage of plaque areas (n = 3–6mice per genotype (A, lower panels); plaque (P) sizes and ATLO sizes in different aorta segments
were quantified as percentage of plaque areas, intima/media, and ATLO/media ratios, respectively (n = 5–10 sections in 3–8mice per genotype) (B, lower panels).
(C and D) Effect of Ltbr deletion on the ATLO structure. Histological and immunofluorescence stainings show ATLO cellularity (C) and HEV abundance (D) in
abdominal aorta segments (n = 5–8 sections in n = 3–4 mice per genotype). Scale bar represents 2.5 mm (A); 100 mm (B); and 50 mm (C and D). Data represent
means ± SEM; p values were determined by two-tailed Student’s t test or by multiple testing (Bonferroni) using the GEE model as described in the Supplemental
Experimental Procedures. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant, p > 0.05; nd, not detectable.and could also impact the balance of pro- versus anti-athero-
genic lymphocytes. However, this favorable fine-tuning of pro-
versus anti-inflammatory lymphocytes could well change under
different conditions. Thus, systemic infections by pathogens,
including those that lead to activation of Toll-like receptors, are
known to activate DCs and antigen-specific TEM and TCM cells
during bouts of exacerbations in multiple sclerosis and rheuma-
toid arthritis (Aloisi and Pujol-Borrell, 2006; Lopez-Diego and
Weiner, 2008), and similar events might occur in atherosclerosis.1112 Immunity 42, 1100–1115, June 16, 2015 ª2015 Elsevier Inc.In summary, these data define interactions between the aging/
senescent immune system, the media of aged arteries, and
hyperlipidemia and characterize the role of abdominal aorta
segments in generating highly territorialized ATLOs. ATLOs
appear to function not only as powerhouses of advanced
atherosclerosis immunity but also seemingly afford strong
protection from advanced atherosclerosis in an age- and site-
specific way. These data raise the important possibility that
TLOs in other forms of unresolvable inflammation also provide
immunoprotection. Further studies are needed to identify mech-
anisms by which ATLO APCs and immune cell subtypes protect
from atherosclerosis. Future studies should also help to isolate
putative (auto)immune T andB cells and to uncovermodes of pe-
ripheral tolerance breakdown during clinical stages of advanced
atherosclerosis. This might facilitate identification of mecha-
nisms underlying the poorly understood phenomenon of acute
exacerbations and relapses in atherosclerosis and autoimmune
diseases. A better understanding of ATLO immunity might thus
be of major clinical significance as TLO-directed therapies are
being evaluated for the treatment of chronic inflammatory dis-
eases, autoimmune diseases, and cancer (Aloisi and Pujol-
Borrell, 2006; Mohanta et al., 2014; Pitzalis et al., 2014; Weyand
et al., 2001).
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J WT and Apoe/ mice were housed in the animal facility of Jena
University. Ltbr/ and Ltbrfl/fl mice were provided by Yang-Xin Fu, University
of Chicago. Tg (Tagln-cre) 1Her/J mice were backcrossed onto the C57BL/6
background for 5 generations using speed congenics. Ltbrfl/flTagln-cre mice
were generated by crossing Ltbrfl/fl mice with Tagln-cremice. Apoe/Ltbr/
and Apoe
/
Ltbrfl/flTagln-cre mice were generated by crossing Apoe/
mice with Ltbr/ or Ltbrfl/flTagln-cre mice. CD45.1/Ly5.1 and Relb/ mice
were bred at the Leibniz-Institute for Age Research Jena. Foxp3-DTR-GFP
mice were provided by Alexander Rudensky. Apoe/CD11c-YFP and OT-II
mice were bred at the Research Facility at the University of Glasgow. Mice
were fed a standard rodent chow and kept under pathogen-free conditions.
Animal procedures were conducted according to guidelines of the local Animal
Use and Care Committees and the National Animal Welfare Laws.
Preparation of Single Cell Suspensions from Aorta, Spleen, LN, and
Blood
Cell suspensions from aorta was prepared by enzyme digestion as previously
described with minor modifications and detailed in the Supplemental Experi-
mental Procedures (Gra¨bner et al., 2009).
Cell Purification and Adoptive Transfers
Lymphocytes from SLOs were isolated from donor mice and injected into
recipient mice, whereas for MPLSM studies, leukocyte cell suspensions and
transgenic CD4+ T cells were prepared from SLOs of WT and OT-II mice,
respectively, and i.v. injected as described in the Supplemental Experimental
Procedures.
Flow Cytometry
Cells for flow cytometry were pretreated with purified anti-mouse CD16/
32 mAb to block Fc receptors as described (Gra¨bner et al., 2009). Cells
were incubated with Abs for 25 min at 4C, washed twice, and, when required,
incubated with secondary mAbs or streptavidin conjugates for 20 min. After
washing, 8-color flow cytometry measurements were performed on a
FACSCanto IITM (BD Bioscience), and data were analyzed using FlowJo
(Tree Star). Antibodies are described in the Supplemental Experimental
Procedures.
Histology, Immunofluorescence, and Morphometry
Tissues were prepared and stored as described (Gra¨bner et al., 2009). 10 mm
cross-sections were prepared and every 10th serial section at 100 mm intervals
was stained with Oil Red O/hematoxylin to delineate ATLOs. Immunofluores-
cence staining was performed as previously described (Gra¨bner et al., 2009),
using marker antibodies as described in online methods. DAPI was used to
stain DNA. Secondary antibodies were used as previously described (Zhao
et al., 2004). For 3D imaging, z stacks were prepared at 0.3 mm intervals using
a Plan Apochromatic 633 differential interference contrast (DIC) oil objective
(NA1.4) with a scan zoom factor 3.1 and then processed with Zen 2009 LightEdition (Zeiss) and further processed as described in the Supplemental Exper-
imental Procedures.
Atherosclerotic Lesion Analyses
Aortas were prepared, stained with Sudan-IV for en face atherosclerosis anal-
ysis, and the extent of atherosclerosis was assessed in total aorta, aortic arch,
descending aorta, and abdominal aorta using ImageJ software as described
(Cao et al., 2009; Schmitt et al., 2014). The extent of atherosclerosis was
assessed in total aorta, aortic arch, descending aorta, and abdominal aorta
using ImageJ software as described in the Supplemental Experimental Proce-
dures. In addition, plaque size and corresponding ATLO size were quantified in
Oil red O/hematoxylin stained serial sections of the innominate artery and
the abdominal aorta below the renal artery at 100 mm intervals as described
(Gra¨bner et al., 2009).
Cell Culture
Aortic VSMCs and ECswere harvested from aortas of 10- to 12-week-oldmice
as described (Gra¨bner et al., 2009) and detailed in the Supplemental Experi-
mental Procedures.
Administration of Ea Antigen
To study the ability of APCs to present systemic antigen, the Ea-GFP/Y-Ae
system was used as previously described (Itano et al., 2003). Briefly, aged
Apoe/ mice were i.v. injected either with 1 mg of Ea antigen or PBS, and
assays were performed 4 hr later.
LCM and Generation of Microarrays
LCM and microarray analyses were performed as previously reported (Gra¨b-
ner et al., 2009; C.Y. and A.J.R.H., unpublished data).
Statistical Analyses
To compare flow cytometry data or morphometry data of multiple mouse
groups, we used the generalized estimating equation model (GEE) as
described in the Supplemental Experimental Procedures.
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